Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma

• Status: Completed
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the efficacy of Once-daily Budesonide/formoterol Turbuhaler 160/4.5 µg/d in the period of step down in well controlled asthmatic patient.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hat Yai Medical Education Center
• Treatments: Budesonide; Formoterol Fumarate

Criteria

Inclusion Criteria:

• Asthmatic patients who have well controlled asthma at least 12 weeks with using budesonide/formoterol (160/4.5 μg/d) twice daily

• Age more than 18 year-old

• Patients who able to do spirometry without contraindication

• History smoking less than 10 pack-years

Exclusion Criteria:

• History of using systemic steroid previous 4 week and respiratory infection

• History of pulmonary tuberculosis with residual lung lesion by chest radiograph

• recent serious medical condition such as myocardial infarction, stroke, pneumonia etc.